Patents by Inventor Ying-Shuan Eda LEE

Ying-Shuan Eda LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of HEC1 activity and methods therefor
    Patent number: 11071736
    Abstract: Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: July 27, 2021
    Inventors: Jiann-Jyh Huang, Shih-Hsien Chuang, Ying-Shuan Eda Lee, Yu-Ling Huang, Johnson Lau
  • Modulators of HEC1 activity and methods therefor
    Patent number: 10588909
    Abstract: Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: March 17, 2020
    Assignees: Taivex Therapeutics Corporation, Development Center For Biotechnology
    Inventors: Jiann-Jyh Huang, Shih-Hsien Chuang, Ying-Shuan Eda Lee, Yu-Ling Huang, Johnson Lau
  • MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR
    Publication number: 20180318310
    Abstract: Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
    Type: Application
    Filed: April 30, 2018
    Publication date: November 8, 2018
    Inventors: Jiann-Jyh HUANG, Shih-Hsien CHUANG, Ying-Shuan Eda LEE, Yu-Ling HUANG, Johnson LAU
  • MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR
    Publication number: 20150250794
    Abstract: Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
    Type: Application
    Filed: March 11, 2015
    Publication date: September 10, 2015
    Inventors: Jiann-Jyh HUANG, Shih-Hsien CHUANG, Ying-Shuan Eda LEE, Yu-Ling HUANG, Johnson LAU
  • Modulators of Hec1 activity and methods therefor
    Patent number: 8999983
    Abstract: Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: April 7, 2015
    Assignees: Taivex Therapeutics Corporation, Development Center of Biotechnology
    Inventors: Jiann-Jyh Huang, Shih-Hsien Chuang, Ying-Shuan Eda Lee, Yu-Ling Huang, Johnson Lau
  • MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR
    Publication number: 20130190312
    Abstract: Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
    Type: Application
    Filed: November 29, 2012
    Publication date: July 25, 2013
    Inventors: Jiann-Jyh HUANG, Shih-Hsien CHUANG, Ying-Shuan Eda LEE, Yu-Ling HUANG, Johnson LAU